Anti-Bevacizumab Antibody (AY12) (recommended for neutralizing assay)
A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF) . Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
Product Specifications
Background
Host
Hybridoma
Origin Species
Mouse
Target
Bevacizumab
Conjugation
Unconjugated
Stability
Purity
0.95
Bioactivity
Demonstration of the specificity of Anti-Bevacizumab Antibody (AY12) (Cat. No. BEB-Y12) to the bevacizumab.
Format
Powder
Buffer
Tris with Glycine, Arginine and NaCl, pH7.5
Additives
Trehalose
Additionnal Information
Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments
Shipping Conditions
RT
Storage Conditions
-20°C
Package Size
100ug*1
Host or Source
Hybridoma
Species
Mouse
Preservative
Trehalose
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Arabidopsis thaliana Cytochrome P450 83B1 (CYP83B1), partial
Recombinant Arabidopsis thaliana Cytochrome P450 83B1 (CYP83B1), partial
Recombinant Arabidopsis thaliana Cytochrome P450 83B1 (CYP83B1), partial
Recombinant Arabidopsis thaliana Cytochrome P450 83B1 (CYP83B1), partial
Recombinant Arabidopsis thaliana Cytochrome P450 83B1 (CYP83B1), partial